Because they can be developed rapidly, mRNA vaccines have the potential to bring personalized care, while others can be mass-produced for general cancer-fighting use.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | A hidden immune backup system could supercharge mRNA cancer vaccines | 0 | 9.29 | 09-07-2026 |
| 2 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 7.74 | 23-10-2026 |
| 3 | Interactive: A cancer vaccine is being tailored to individuals | 0 | 12.1 | 19-08-2026 |
| 4 | Разработана вакцина для терапии рака легкого | 0 | 7.66 | 23-09-2026 |
| 5 | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning | 0 | 9.7 | 22-10-2026 |
| 6 | What is Moderna’s new cancer vaccine and how big a breakthrough is it? | 0 | 6.64 | 20-08-2026 |
| 7 | Ученые разработали прототип мРНК-вакцины для лечения рака легкого | 0 | 22.5 | 23-09-2026 |
| 8 | РНК-вакцины против рака: персонализированная терапия | 0 | 21.89 | 06-10-2026 |
| 9 | Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success | 0 | 7.16 | 15-10-2026 |